Abstract
While disease is an observable phenomenon at the cellular and biochemical level, the reasons that the human system lapses into disease and dysfunctions are more complex than the end-stage pathological finding. This chapter looks at how these dysfunctions occur over time, as this is the ground of chronic ill health of the kind that patients seek help for. Alterations to normal function precede the degenerative changes that lead to chronic disease. These alterations can certainly present with symptoms, sometimes drastic, but they have the potential to be reversed. Allopathic medications sometimes work effectively in dampening these alterations. But if the disturbances that caused abnormal function are left unaddressed, it is likely that more aggressive treatment will be needed and that degenerative changes will occur. Examples discussed in this chapter include disorganization of normal regulatory feedback loops, breakdown and stiffening of the extracellular matrix, depletion of stem cell reserves, mitochondrial dysfunction, attenuation of pro-survival responses to stimuli and stressors, degradation of the proteome, and neoplasia-uncontrolled growth and differentiation. The chapters that follow will examine the etiological causes of these breakdowns and their relation to disease development.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Franco E, Galloway KE. Feedback loops in biological networks. Methods Mol Biol. 2015;1244:193–214.
Smith A, Bianchi A, Kuestermann K, O’Byrne A, Van Brandt B. Introduction to bioregulatory medicine. Stuttgart: Thieme; 2009.
Gonze D, Ruoff P. The Goodwin oscillator and its legacy. Acta Biotheor. 2020;69:857.
Stiles PJ, Gray CG. Improved Hodgkin-Huxley type model for neural action potentials. Eur Biophys J. 2021;50(6):819–28.
Blanchini F, Cuba Samaniego C, Franco E, Giordano G. Homogeneous time constants promote oscillations in negative feedback loops. ACS Synth Biol. 2018;7(6):1481–7.
Ananthasubramaniam B, Herzel H. Positive feedback promotes oscillations in negative feedback loops. PLoS One. 2014;9(8):e104761.
Gjerstad JK, Lightman SL, Spiga F. Role of glucocorticoid negative feedback in the regulation of HPA axis pulsatility. Stress. 2018;21(5):403–16.
Pomatto LCD, Davies KJA. The role of declining adaptive homeostasis in ageing. J Physiol. 2017;595(24):7275–309.
Davies KJA. Adaptive homeostasis. Mol Asp Med. 2016;49:1–7. https://pubmed.ncbi.nlm.nih.gov/27112802.
Lauzon RJ, Ishizuka KJ, Weissman IL. Cyclical generation and degeneration of organs in a colonial urochordate involves crosstalk between old and new: a model for development and regeneration. Dev Biol. 2002;249(2):333–48.
Abedi F, Rezaee R, Hayes AW, Nasiripour S, Karimi G. MicroRNAs and SARS-CoV-2 life cycle, pathogenesis, and mutations: biomarkers or therapeutic agents? Cell Cycle. 2021;20(2):143–53.
Ac IAH, Histology M. Matrix Histol Physiol. 2007:1–55.
Yue B. Biology of the extracellular matrix: an overview. J Glaucoma. 2014;23(8 Suppl 1):S20–3. https://pubmed.ncbi.nlm.nih.gov/25275899.
Pickup MW, Mouw JK, Weaver VM. The extracellular matrix modulates the hallmarks of cancer. EMBO Rep. 2014;15(12):1243–53.
Moreira AM, Pereira J, Melo S, Fernandes MS, Carneiro P, Seruca R, et al. The extracellular matrix: an accomplice in gastric cancer development and progression. Cells. 2020;9(2):394.
Kai F, Drain AP, Weaver VM. The extracellular matrix modulates the metastatic journey. Dev Cell. 2019;49(3):332–46.
Filipe EC, Chitty JL, Cox TR. Charting the unexplored extracellular matrix in cancer. Int J Exp Pathol. 2018;99(2):58–76.
Mohanraj K, Nowicka U, Chacinska A. Mitochondrial control of cellular protein homeostasis. Biochem J. 2020;477(16):3033–54.
Bhatti JS, Bhatti GK, Reddy PH. Mitochondrial dysfunction and oxidative stress in metabolic disorders - a step towards mitochondria based therapeutic strategies. Biochim Biophys Acta Mol basis Dis. 2017;1863(5):1066–77.
Nunnari J, Suomalainen A. Mitochondria: in sickness and in health. Cell. 2012;148(6):1145–59.
Giorgi C, Marchi S, Simoes ICM, Ren Z, Morciano G, Perrone M, et al. Mitochondria and reactive oxygen species in aging and age-related diseases. Int Rev Cell Mol Biol. 2018;340:209–344. https://pubmed.ncbi.nlm.nih.gov/30072092.
Meyer JN, Leuthner TC, Luz AL. Mitochondrial fusion, fission, and mitochondrial toxicity. Toxicology. 2017;391:42–53.
Brand MD, Nicholls DG. Assessing mitochondrial dysfunction in cells. Biochem J. 2011;435(2):297–312. https://pubmed.ncbi.nlm.nih.gov/21726199.
Srinivasan S, Guha M, Kashina A, Avadhani NG. Mitochondrial dysfunction and mitochondrial dynamics-the cancer connection. Biochim Biophys Acta Bioenerg. 2017;1858(8):602–14.
Calabrese EJ. Hormesis and stem cells enhancing cell proliferation, differentiation and resilience to inflammatory stress in bone marrow stem cells and their therapeutic implications. Chem Biol Interact. 2021;351:109730. https://doi.org/10.1016/j.cbi.2021.109730.
Gehart H, Clevers H. Tales from the crypt: new insights into intestinal stem cells. Nat Rev Gastroenterol Hepatol. 2019;16(1):19–34.
Brundel BJJM. The role of proteostasis derailment in cardiac diseases. Cells. 2020;9(10):2317. https://pubmed.ncbi.nlm.nih.gov/33086474.
Roth DM, Balch WE. Modeling general proteostasis: proteome balance in health and disease. Curr Opin Cell Biol. 2011;23(2):126–34.
Morimoto RI, Cuervo AM. Proteostasis and the aging proteome in health and disease. J Gerontol A Biol Sci Med Sci. 2014;69(Suppl 1):S33–8.
Alvarez-Garcia I, Miska EA. MicroRNA functions in animal development and human disease. Development. 2005;132(21):4653–62.
Ge H, Tian M, Pei Q, Tan F, Pei H. Extracellular matrix stiffness: new areas affecting cell metabolism. Front Oncol. 2021;11:631991. https://pubmed.ncbi.nlm.nih.gov/33718214.
Theocharis AD, Manou D, Karamanos NK. The extracellular matrix as a multitasking player in disease. FEBS J. 2019;286(15):2830–69.
Faas MM, de Vos P. Mitochondrial function in immune cells in health and disease. Biochim Biophys Acta Mol basis Dis. 2020;1866(10):165845.
Verma SK, Garikipati VNS, Kishore R. Mitochondrial dysfunction and its impact on diabetic heart. Biochim Biophys Acta Mol basis Dis. 2017;1863(5):1098–105.
Lu P, Takai K, Weaver VM, Werb Z. Extracellular matrix degradation and remodeling in development and disease. Cold Spring Harb Perspect Biol. 2011;3(12):a005058. https://pubmed.ncbi.nlm.nih.gov/21917992.
Monnier VM, Sell DR, Nagaraj RH, Miyata S, Grandhee S, Odetti P, et al. Maillard reaction-mediated molecular damage to extracellular matrix and other tissue proteins in diabetes, aging, and uremia. Diabetes. 1992;41(Suppl 2):36–41.
Burgstaller G, Oehrle B, Gerckens M, White ES, Schiller HB, Eickelberg O. The instructive extracellular matrix of the lung: basic composition and alterations in chronic lung disease. Eur Respir J. 2017;50(1):1601805. http://erj.ersjournals.com/content/50/1/1601805.abstract.
Brunet A, Berger SL. Epigenetics of aging and aging-related disease. J Gerontol A Biol Sci Med Sci. 2014;69(Suppl 1):S17–20.
Walker C, Mojares E, Del RÃo Hernández A. Role of Extracellular Matrix in Development and Cancer Progression. Int J Mol Sci. 2018;19(10):3028.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Smith, F. (2022). Theory of Disease. In: Naturopathic Medicine. Springer, Cham. https://doi.org/10.1007/978-3-031-13388-6_2
Download citation
DOI: https://doi.org/10.1007/978-3-031-13388-6_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-13387-9
Online ISBN: 978-3-031-13388-6
eBook Packages: MedicineMedicine (R0)